Icodex Publish.

How has been the historical performance of Icodex Publish.?

Icodex Publish has shown strong financial growth over the past two years, with net sales increasing to 10.40 Cr in March 2024 from 9.54 Cr in March 2023, and profit after tax rising to 4.40 Cr from 1.81 Cr. Key metrics such as operating profit margin and total assets have also improved significantly during this period.

Answer:<BR>The historical performance of Icodex Publish shows a positive trend in key financial metrics over the past two years.<BR><BR>Breakdown:<BR>In the standalone annual results for March 2024, Icodex Publish reported net sales of 10.40 Cr, an increase from 9.54 Cr in March 2023. Total operating income also rose to 10.40 Cr from 9.54 Cr, while total expenditure decreased to 6.14 Cr from 7.59 Cr, leading to an operating profit (PBDIT) of 4.85 Cr, up from 2.13 Cr the previous year. Profit before tax improved significantly to 4.45 Cr from 1.84 Cr, resulting in a profit after tax of 4.40 Cr compared to 1.81 Cr in the prior year. The operating profit margin increased to 40.96% from 20.44%, and the profit after tax margin rose to 42.31% from 18.97%. On the balance sheet, total assets grew to 24.75 Cr in March 2025 from 10.67 Cr in March 2024, with total liabilities also increasing to 24.75 Cr from 10.67 Cr. Cash flow from operating activities improved to 6.00 Cr from 3.00 Cr, while cash flow from investing activities showed a larger outflow of -9.00 Cr compared to -3.00 Cr the previous year. Overall, Icodex Publish has demonstrated strong growth in sales, profitability, and asset accumulation over the reported periods.

Is Icodex Publish. overvalued or undervalued?

As of November 18, 2025, Icodex Publish. is rated very attractive and undervalued with a PE ratio of 9.77 and strong ROCE of 35.32%, significantly outperforming peers like TCS and Infosys, despite recent underperformance against the Sensex, while showing a robust 21.45% return over the past month.

As of 18 November 2025, the valuation grade for Icodex Publish. has moved from does not qualify to very attractive, indicating a significant improvement in its perceived value. The company is currently assessed as undervalued, supported by a PE ratio of 9.77, an EV to EBIT of 5.39, and a robust ROCE of 35.32%. <BR><BR>In comparison to its peers, TCS has a PE ratio of 22.2 and EV to EBITDA of 15.6, while Infosys shows a PE of 21.95 and an EV to EBITDA of 14.37. These comparisons highlight Icodex Publish.'s favorable valuation metrics relative to established competitors in the software products industry. Additionally, while the stock has recently underperformed the Sensex over the past week, it has shown a strong return of 21.45% over the past month, reinforcing the potential for growth as it aligns more closely with its intrinsic value.

When is the next results date for Icodex Publishing Solutions Ltd?

The next results date for Icodex Publishing Solutions Ltd is 15 May 2026.

The next results date for Icodex Publishing Solutions Ltd is scheduled for 15 May 2026.

Why is Icodex Publishing Solutions Ltd falling/rising?

As of 24-May, Icodex Publishing Solutions Ltd's stock price is at 43.00, reflecting a decline of 4.44%. The stock has underperformed significantly over the past week and is trading below key moving averages, indicating a bearish sentiment among investors.

As of 24-May, Icodex Publishing Solutions Ltd's stock price is falling, currently at 43.00, which reflects a decrease of 2.0 or 4.44%. This decline is evident in the stock's performance over the past week, where it has underperformed significantly, dropping by 9.47%, while the benchmark Sensex has only increased by 0.24%. The stock also opened with a loss of 4% today and reached an intraday low of Rs 42.59, marking a decrease of 5.36%.<BR><BR>Additionally, the stock's performance today has been characterized by erratic trading, as it did not trade on one day out of the last 20 days. The weighted average price indicates that more volume was traded closer to the low price, suggesting a lack of investor confidence. Although there has been a slight increase in delivery volume by 13.64% against the five-day average, this has not been sufficient to counteract the overall negative trend. The stock is currently trading below several moving averages, including the 5-day, 20-day, 100-day, and 200-day moving averages, which further indicates a bearish sentiment among investors. Overall, these factors contribute to the stock's decline.

Which are the latest news on Icodex Publish.?